Pim Kinase Inhibitors Evaluated with a Single-Molecule Engineered Nanopore Sensor

Angew Chem Int Ed Engl. 2015 Jul 6;54(28):8154-9. doi: 10.1002/anie.201503141. Epub 2015 Jun 8.

Abstract

Protein kinases are critical therapeutic targets. Pim kinases are implicated in several leukaemias and cancers. Here, we exploit a protein nanopore sensor for Pim kinases that bears a pseudosubstrate peptide attached by an enhanced engineering approach. Analyte binding to the sensor peptide is measured through observation of the modulation of ionic current through a single nanopore. We observed synergistic binding of MgATP and kinase to the sensor, which was used to develop a superior method to evaluate Pim kinase inhibitors featuring label-free determination of inhibition constants. The procedure circumvents many sources of bias or false-positives inherent in current assays. For example, we identified a potent inhibitor missed by differential scanning fluorimetry. The approach is also amenable to implementation on high throughput chips.

Keywords: drug discovery; inhibitors; protein kinases; screening; single-molecule studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Discovery
  • Molecular Structure
  • Nanopores
  • Protein Kinase Inhibitors / chemistry*
  • Protein Kinases / metabolism*
  • Proto-Oncogene Proteins c-pim-1 / antagonists & inhibitors*

Substances

  • Protein Kinase Inhibitors
  • Protein Kinases
  • Proto-Oncogene Proteins c-pim-1
  • proto-oncogene proteins pim